Roivant Sciences
Price & Volume
Stats
See more52W Range | $10.90-$37 |
Market Cap | $25.8B |
Shares Short | 33M |
Financials
See moreRevenue (12 Mos) | $8.2M |
Revenue Growth (YoY) | -66.7% |
Gross Profit (12 Mos) | -$673.9M |
Diluted EPS | -$0.54 |
News
See moreYahoo Finance • 5 days ago
Could Roivant Sciences Be a Multibagger Stock Over the Next 5 Years?
Yahoo Finance • last month
Guggenheim Remains Bullish on Roivant Sciences Ltd. (ROIV)
Yahoo Finance • 2 months ago
Roivant anticipates $950M Moderna payment in July as it outlines 2H 2026 mosliciguat and IMVT-1402 readouts
Yahoo Finance • 2 months ago
Roivant (ROIV) Q4 2025 Earnings Transcript
About
CEO | Mr. Matthew Gline |
Address | 50 Broadway, London, United Kingdom, SW1H 0DB |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 721 |